The FDA Proposes Adding Warning Labels to Breast Implants

France Nouvelles Nouvelles

The FDA Proposes Adding Warning Labels to Breast Implants
France Dernières Nouvelles,France Actualités
  • 📰 Allure_magazine
  • ⏱ Reading Time:
  • 58 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 51%

Here's what you need to know.

, and those who have received them.

In February, the Food and Drug Administration issued a new update, citing more cases of a rare lymphoma cancer, BIA-ALCL, associated with breast implants. The next month, the FDA hosted a public, in Maryland, attended by plastic surgeons, manufacturers, and included personal testimonies from women who attribute their health problems to their implants.attended the March meeting and agrees that more effort needs to be put into patient education, industry-wide. According to Sieber, patients at the meeting were not only sharing that they were uninformed of risks, but that "they also felt like many plastic surgeons were being very dismissive of their symptoms.

, including a boxed warning on implant packaging and a "patient decision checklist," which is intended to standardize and guide doctor-patient conversations by outlining all potential risks. "We have heard from many women that they are not fully informed of the risks when considering breast implants," said Amy Abernethy, principal deputy commissioner of the FDA, and Jeff Shuren, director of the FDA's center for devices and radiological health in

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Allure_magazine /  🏆 473. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Trump bets on Washington outsider to lead FDA amid political battlesTrump bets on Washington outsider to lead FDA amid political battles
Lire la suite »

FDA panel recommends withdrawing approval of Makena drug, used to prevent preterm birthsFDA panel recommends withdrawing approval of Makena drug, used to prevent preterm birthsA committee for the US Food and Drug Administration now recommends that the approval of Makena, a drug used to reduce the risk of preterm births, should be withdrawn — and some women who have used the medication are sounding the alarm
Lire la suite »

Zantac does not form impurity in users, FDA saysZantac does not form impurity in users, FDA saysAs part of its investigation into an impurity found in heartburn medication Zantac OTC, the US Food and Drug Administration has found levels of the impurity 'similar to the levels you would expect to be exposed to if you ate common foods like grilled or smoked meats.'
Lire la suite »

Trump to pick Texas cancer doctor to head FDATrump to pick Texas cancer doctor to head FDA
Lire la suite »

FDA testing indicates Zantac does not form carcinogen in usersFDA testing indicates Zantac does not form carcinogen in usersThe results come from lab tests, but the agency said that it still plans to test the drug in human patients.
Lire la suite »



Render Time: 2025-04-05 09:43:13